The continuing evolution of barcode applications: Functional toxicology to cell lineage.
Michael FasulloMichael DolanPublished in: Experimental biology and medicine (Maywood, N.J.) (2022)
DNA barcoding is a method to identify biological entities, including individual cells, tissues, organs, or species, by unique DNA sequences. With the advent of next generation sequencing (NGS), there has been an exponential increase in data acquisition pertaining to medical diagnosis, genetics, toxicology, ecology, cancer, and developmental biology. While barcoding first gained wide access in identifying species, signature tagged mutagenesis has been useful in elucidating gene function, particularly in microbes. With the advent of CRISPR/CAS9, methodology to profile eukaryotic genes has made a broad impact in toxicology and cancer biology. Designed homing guide RNAs (hgRNAs) that self-target DNA sequences facilitate cell lineage barcoding by introducing stochastic mutations within cell identifiers. While each of these applications has their limitations, the potential of sequence barcoding has yet to be realized. This review will focus on signature-tagged mutagenesis and briefly discuss the history of barcoding, experimental problems, novel detection methods, and future directions.
Keyphrases
- crispr cas
- single cell
- circulating tumor
- cell therapy
- genome editing
- papillary thyroid
- cell free
- mental health
- gene expression
- induced apoptosis
- copy number
- squamous cell carcinoma
- machine learning
- mesenchymal stem cells
- electronic health record
- nucleic acid
- young adults
- risk assessment
- climate change
- quantum dots
- pi k akt
- endoplasmic reticulum stress